Skip to main content

Esperanza Esteban Serna

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Esperanza Esteban Serna

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

MyHealth: Models to engage Migrants and Refugees in their health, through Community Empowerment and Learning Alliance.

IP: Nuria Serre Delcor
Collaborators: Tahir Rafi Khanum, Estefa Choque Apaico, Abdallah Denial, Esperanza Esteban Serna
Funding agency: Ex. Agency for Health Consumers (EAHC)-CHAFEA
Funding: 348276.86
Reference: MYHEALTH_3HP-CHAFEA2016
Duration: 01/04/2017 - 30/06/2020

PICAT (Plataforma Integral per al Control d¿ Arbovirosis a CaTalunya)

IP: Israel Molina Romero
Collaborators: Diana Pou Ciruelo, Fernando M Salvador Velez, Esperanza Esteban Serna, Raisa Morales Martinez, Adrián Sánchez Montalvá, Elena Sulleiro Igual
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 125216.28
Reference: SLT002/16/00466
Duration: 01/01/2017 - 31/12/2019

Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Núria Pérez Picazo, Fernando M Salvador Velez, Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Olga Sánchez- Maroto Carrizo, Esperanza Esteban Serna
Funding agency: EUROPEAN COMMISSION
Funding: 939958.88
Reference: BERENICE_FP7HEALTH2012
Duration: 01/09/2012 - 31/08/2018

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

More than 50 healthcare professionals and community agents in Benguela receive specialized training to improve the detection and support of women with perinatal disorders.

According to the results, the team highlights the need to use combinations of drugs to reactivate all HIV reservoirs and eliminate the virus from the different tissues where it remains silent.

Related professionals

Mario Marotta Baleriola

Mario Marotta Baleriola

Postdoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Laura Castellote Bellés

Laura Castellote Bellés

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Susana  Manrique Muñoz

Susana Manrique Muñoz

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Marta Valeri Sala

Marta Valeri Sala

Senior Technician - MICINN - C
High Technology Unit (UAT)
Preclinical Core Facilities
External Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.